← Back to Search

uTECH Social Media Intervention for HIV Prevention (uTECH Trial)

N/A
Waitlist Available
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Have had anal and/or oral sex with a man in the past 3 months
18 years of age or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

uTECH Trial Summary

This trial will test a new social media intervention for people who use drugs and have sex with men, to help reduce HIV transmission risk. The intervention includes biomedical and behavioral strategies, like PrEP and MAT.

Who is the study for?
This trial is for HIV-negative, substance-using gender and sexual minority men in Los Angeles who use social media apps to find partners. Participants must be adults comfortable with English and using a smartphone app that monitors text-based data. They should have had sex while under the influence of substances within the last three months.Check my eligibility
What is being tested?
The study is testing uTECH, an intervention using machine learning from social media data to reduce HIV risk by promoting strategies like PrEP for HIV prevention and MAT for substance use. It's compared against uTECH + YMHP (Youth Messaging for Health Project) and just YMHP alone.See study design
What are the potential side effects?
Since this trial involves behavioral interventions rather than medications, traditional side effects are not expected. However, participants may experience privacy concerns or emotional discomfort from discussing personal behaviors.

uTECH Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have had anal or oral sex with a man in the last 3 months.
Select...
I am 18 years old or older.
Select...
I identify as a gender minority.

uTECH Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Perception of Intervention Acceptability [4-item scale, 5-point ordinal response]
Perception of Intervention Appropriateness [4-item scale, 5-point ordinal response]
Perception of Intervention Feasibility [4-item scale, 5-point ordinal response]

uTECH Trial Design

3Treatment groups
Active Control
Group I: uTECHActive Control1 Intervention
Approximately 60 participants will be randomly assigned to this arm and will receive the uTECH intervention over the course of 12 months.
Group II: Young Men's Health Project (YMHP)Active Control1 Intervention
Approximately 165 participants will be randomly assigned to this arm and will receive the YMHP intervention over the course of the first 3 months. Months 3-12 will be inactive, and they will be followed for a total of 12 months.
Group III: uTECH + Young Men's Health Project (YMHP)Active Control1 Intervention
Approximately 165 participants will be randomly assigned to this arm and will receive the uTECH intervention over the course of 12 months and YMHP intervention over the course of 3 months.

Find a Location

Who is running the clinical trial?

National Institute on Drug Abuse (NIDA)NIH
2,464 Previous Clinical Trials
2,618,205 Total Patients Enrolled
University of California, Los AngelesLead Sponsor
1,528 Previous Clinical Trials
10,276,463 Total Patients Enrolled

Media Library

uTECH Clinical Trial Eligibility Overview. Trial Name: NCT04710901 — N/A
Human Immunodeficiency Virus Infection Research Study Groups: uTECH, Young Men's Health Project (YMHP), uTECH + Young Men's Health Project (YMHP)
Human Immunodeficiency Virus Infection Clinical Trial 2023: uTECH Highlights & Side Effects. Trial Name: NCT04710901 — N/A
uTECH 2023 Treatment Timeline for Medical Study. Trial Name: NCT04710901 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals are participating in this research initiative?

"Affirmative, the information available on clinicaltrials.gov indicates that this research is actively recruiting participants. The initial posting of the trial occurred on November 24th 2020 and was recently updated on May 23rd 2022 with a goal to enroll 335 patients at one particular site."

Answered by AI

Is recruitment for this trial still taking place?

"As indicated by clinicaltrials.gov, this medical trial is actively searching for patients after being initially posted on November 24th 2020 and then edited as recently as May 23rd 2022."

Answered by AI
~9 spots leftby May 2024